首页> 外文期刊>Journal of Clinical Microbiology >Development of a Sensitive and Specific Assay Combining Multiplex PCR and DNA Microarray Primer Extension To Detect High-Risk Mucosal Human Papillomavirus Types
【24h】

Development of a Sensitive and Specific Assay Combining Multiplex PCR and DNA Microarray Primer Extension To Detect High-Risk Mucosal Human Papillomavirus Types

机译:结合多重PCR和DNA芯片引物扩展,以检测高危粘膜人类乳头瘤病毒类型的灵敏和特异检测方法的开发

获取原文
           

摘要

The importance of assays for the detection and typing of human papillomaviruses (HPVs) in clinical and epidemiological studies has been well demonstrated. Several accurate methods for HPV detection and typing have been developed. However, comparative studies showed that several assays have different sensitivities for the detection of specific HPV types, particularly in the case of multiple infections. Here, we describe a novel one-shot method for the detection and typing of 19 mucosal high-risk (HR) HPV types (types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 70, 73, and 82). This assay combines two different techniques: multiplex PCR with HPV type-specific primers for amplification of viral DNA and array primer extension (APEX) for typing. This novel method has been validated with artificial mixtures of HPV DNAs and clinical samples that were already analyzed for the presence of mucosal HPV types by a different consensus PCR method, i.e., GP5+/GP6+. Our data showed a very good agreement between the results from the multiplex PCR/APEX assay and those from the GP5+/GP6+ PCR (overall rates of HPV positivity, 63.0 and 60.9%, respectively). Whereas the GP5+/GP6+ PCR was slightly more sensitive for the detection of HPV type 16 (HPV-16), multiplex PCR-APEX found a higher number of infections with HPV-33, HPV-53, and multiple HPV types. These favorable features and the high-throughput potential make our present novel assay ideal for large-scale clinical and epidemiological studies aimed at determining the spectrum of mucosal HR HPV types in cervical specimens.
机译:在临床和流行病学研究中,检测对人乳头瘤病毒(HPV)的检测和分型的重要性已得到充分证明。已经开发了几种用于HPV检测和分型的准确方法。但是,比较研究表明,几种检测方法对特定HPV类型的检测具有不同的敏感性,尤其是在多重感染的情况下。在这里,我们描述了一种新颖的单发方法,用于检测和分类19种黏膜高危(HR)HPV类型(16、18、26、31、33、35、39、45、51、52、53, 56、58、59、66、68、70、73和82)。该测定法结合了两种不同的技术:用于扩增病毒DNA的HPV类型特异性引物的多重PCR和用于分型的阵列引物延伸(APEX)。该新方法已被HPV DNA和临床样品的人工混合物验证,该混合物已通过不同的共有PCR方法(即GP5 + / GP6 +)分析了粘膜HPV类型的存在。我们的数据显示,多重PCR / APEX分析结果与GP5 + / GP6 + PCR结果之间有很好的一致性(HPV阳性的总比率分别为63.0和60.9%)。 GP5 + / GP6 + PCR对检测16型HPV(HPV-16)的敏感性稍高,而多重PCR-APEX发现HPV-33,HPV-53和多种HPV类型的感染率更高。这些有利的功能和高通量的潜力使我们目前新颖的检测方法成为大规模临床和流行病学研究的理想选择,这些研究旨在确定宫颈标本中粘膜HR HPV类型的光谱。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号